← Today in NEWSDASH.LIVE
The logic of a pharma megamerger is questionable, but AstraZeneca’s record isn’t.
2 outlets
·
Stocks
How each outlet headlined it
WSJ Markets
right
The logic of a pharma megamerger is questionable, but AstraZeneca’s record isn’t.
CNBC
left
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale